FDA Expands Indication of Antiviral Therapy to Include Post-Exposure Influenza Prevention
November 23, 2020 09:45pm
A set of 43 consensus recommendations was developed by an international panel of leading experts in clinical nutrition, lipid metabolism, and pharmacology.
Expert guidance on the use of fish oil-containing lipid emulsions in clinical practice has been provided by Fresenius Kabi in “Lipids in Parenteral Nutrition: Translating Guidelines into Clinical Practice.” Published inThe Journal of Parenteral and Enteral Nutrition(JPEN), the resource represents the largest set of expert consensus statements on the topic, according to the company.1
Parenteral nutrition is a method of receiving nutrition through your veins, and is used to help people who cannot or should not get their core nutrients from food. This method is often used for patients with cancer, Crohn disease, and ischemic bowel disease.2
A set of 43 consensus recommendations was developed by an international panel of leading experts in clinical nutrition, lipid metabolism, and pharmacology. The recommendations are intended to help health care professionals navigate issues around prescription, administration, safety, and monitoring of lipids.1
Fish oil-containing parenteral nutrition has been shown to have a variety of beneficial effects on key biological functions. These benefits include modulation of the immune and inflammatory response, and growing evidence suggests that these properties improve clinical outcomes, such as infection rates, length of ICU, and hospital stay.1
The current guidelines of international clinical societies recommend the use of fish oil-containing lipid emulsions in parenteral nutrition. However, when regarding specific nutrients, only parenteral lipid emulsions with EPA + DHA are recommended by the European Society for Clinical Nutrition and Metabolism guideline on clinical nutrition in the intensive care unit.1